Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Olga Zozulya"'
Autor:
Ekaterina Akulova, Boris Murashev, Sergey Verevochkin, Alexey Masharsky, Ruslan Al-Shekhadat, Valeriy Poddubnyy, Olga Zozulya, Natalia Vostokova, Andrei P. Kozlov
Publikováno v:
Vaccines, Vol 7, Iss 3, p 92 (2019)
We developed a candidate DNA vaccine called “DNA-4”consisting of 4 plasmid DNAs encoding Nef, Gag, Pol(rt), and gp140 HIV-1 proteins. The vaccine was found to be safe and immunogenic in a phase I clinical trial. Here we present the results of a p
Externí odkaz:
https://doaj.org/article/4799e6fa02604a4ab93ed3367ddf8ae8
Autor:
Vladimir Egorov, Olga Zozulya
Publikováno v:
OOO "Zhurnal "Voprosy Istorii". 2021:51-73
The article describes the current state of Russian handicraft industry research and outlines benchmarks for further studies. According to the authors, the completed historiographical path and the introduction of a wide range of sources into scientifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c95a34c7bf33548906a8e98a1a4932b
https://doi.org/10.31166/voprosyistorii202104statyi03
https://doi.org/10.31166/voprosyistorii202104statyi03
Autor:
Olga Zozulya, Valeriy Poddubnyy, Sergey V. Verevochkin, Natalia Vostokova, Ekaterina Akulova, Boris Murashev, Ruslan Al-Shekhadat, A. P. Kozlov, Alexey Masharsky
Publikováno v:
Vaccines, Vol 7, Iss 3, p 92 (2019)
Vaccines
Volume 7
Issue 3
Vaccines
Volume 7
Issue 3
We developed a candidate DNA vaccine called &ldquo
DNA-4&rdquo
consisting of 4 plasmid DNAs encoding Nef, Gag, Pol(rt), and gp140 HIV-1 proteins. The vaccine was found to be safe and immunogenic in a phase I clinical trial. Here we present
DNA-4&rdquo
consisting of 4 plasmid DNAs encoding Nef, Gag, Pol(rt), and gp140 HIV-1 proteins. The vaccine was found to be safe and immunogenic in a phase I clinical trial. Here we present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3f901586f231a020864fc4a33aa1fb6
https://www.mdpi.com/2076-393X/7/3/92
https://www.mdpi.com/2076-393X/7/3/92
Publikováno v:
Socium i vlast. :135-139
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dce7c6a748daa13c87757b1c94c8ca67
https://doi.org/10.22394/1996-0522-2017-3-135-139
https://doi.org/10.22394/1996-0522-2017-3-135-139
Publikováno v:
Socium i vlast. :125-130
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::313a309403ed8c4075f1128637bd74a8
https://doi.org/10.22394/1996-0522-2017-6-125-130
https://doi.org/10.22394/1996-0522-2017-6-125-130
Publikováno v:
Socium i vlast. :113-117
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a5ef5d52ad9c7ea032998ffe8d0d3e5
https://doi.org/10.22394/1996-0522-2017-2-113-117
https://doi.org/10.22394/1996-0522-2017-2-113-117
Publikováno v:
Pharmacological Research. 31:354
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0266a6881927826c09ca5116e1441711
https://doi.org/10.1016/1043-6618(95)87676-6
https://doi.org/10.1016/1043-6618(95)87676-6